Healthcare provider profile · identity verified

Joseph Guy Donzella, DO

Family Practice · WHEELING, WV · NPI 1831190206

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	610	164
Rosuvastatin Calcium	Rosuvastatin Calcium	418	121
Amlodipine Besylate	Amlodipine Besylate	359	99
Omeprazole	Omeprazole	250	70
Simvastatin	Simvastatin	230	60
Losartan Potassium	Losartan Potassium	221	65
Gabapentin	Gabapentin	219	48
Tamsulosin Hcl	Tamsulosin Hcl	207	57
Metformin Hcl	Metformin Hcl	201	55
Lisinopril	Lisinopril	194	53
Hydrochlorothiazide	Hydrochlorothiazide	184	52
Ozempic	Semaglutide	164	30
Levothyroxine Sodium	Levothyroxine Sodium	161	44
Metoprolol Succinate	Metoprolol Succinate	160	48
Valsartan	Valsartan	155	43
Pantoprazole Sodium	Pantoprazole Sodium	143	46
Jardiance	Empagliflozin	142	37
Metformin Hcl Er	Metformin Hcl	133	39
Allopurinol	Allopurinol	129	38
Eliquis	Apixaban	129	27
Meloxicam	Meloxicam	119	34
Furosemide	Furosemide	111	29
Atenolol	Atenolol	110	29
Famotidine	Famotidine	110	27
Ezetimibe	Ezetimibe	107	30
Duloxetine Hcl	Duloxetine Hcl	106	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	102	26
Trazodone Hcl	Trazodone Hcl	100	22
Finasteride	Finasteride	86	22
Pravastatin Sodium	Pravastatin Sodium	85	24
Sertraline Hcl	Sertraline Hcl	79	20
Citalopram Hbr	Citalopram Hydrobromide	76	22
Clopidogrel	Clopidogrel Bisulfate	68	15
Montelukast Sodium	Montelukast Sodium	67	18
Zolpidem Tartrate	Zolpidem Tartrate	67	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	61	15
Mounjaro	Tirzepatide	59	11
Pregabalin	Pregabalin	58	suppressed
Potassium Chloride	Potassium Chloride	57	17
Carvedilol	Carvedilol	56	17
Metoprolol Tartrate	Metoprolol Tartrate	52	14
Synthroid	Levothyroxine Sodium	52	13
Alendronate Sodium	Alendronate Sodium	51	14
Mirtazapine	Mirtazapine	48	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	47	12
Spironolactone	Spironolactone	46	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	11
Xarelto	Rivaroxaban	42	suppressed
Farxiga	Dapagliflozin Propanediol	38	suppressed
Tresiba Flextouch U-200	Insulin Degludec	38	suppressed
Glimepiride	Glimepiride	35	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	13
Celecoxib	Celecoxib	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	12
Donepezil Hcl	Donepezil Hcl	31	suppressed
Methocarbamol	Methocarbamol	29	suppressed
Methylprednisolone	Methylprednisolone	28	26
Benazepril Hcl	Benazepril Hcl	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Tresiba Flextouch U-100	Insulin Degludec	25	suppressed
Glipizide	Glipizide	24	suppressed
Ketoconazole	Ketoconazole	24	16
Eszopiclone	Eszopiclone	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Dutasteride	Dutasteride	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	19	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	18	suppressed
Silodosin	Silodosin	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Torsemide	Torsemide	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amoxicillin	Amoxicillin	13	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Prednisone	Prednisone	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error